Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo


Birch, EE; Castaneda, YS; Wheaton, DH; Birch, DG; Uauy, RD; Hoffman, DR; (2005) Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. The American journal of clinical nutrition, 81 (4). pp. 871-9. ISSN 0002-9165

Full text not available from this repository.

Abstract

BACKGROUND: Several studies found a benefit of long-chain polyunsaturated fatty acid (LCP) supplementation for visual or mental development, but others found no benefit. Likely contributors to differences among studies are the amount of LCP supplementation, functional outcomes, and sample size. OBJECTIVE: We evaluated LCP supplementation in amounts typical for human milk (based on local and worldwide surveys) in a large cohort of infants by using sweep visual evoked potential (VEP) acuity as the functional outcome. DESIGN: The study was a double-masked, randomized, controlled clinical trial in 103 term infants. By age 5 d, infants were randomly assigned to receive either formula with no docosahexaenoic acid (DHA) or arachidonic acid (ARA) or formula supplemented with DHA and ARA as 0.36% and 0.72%, respectively, of total fatty acids. Sweep VEP acuity was the primary outcome. Random dot stereoacuity, blood lipid profile, growth, and tolerance were secondary outcomes. RESULTS: VEP acuity in the LCP-supplemented group was significantly better than that in the control group at ages 6, 17, 26, and 52 wk. Stereoacuity in the LCP-supplemented group was significantly better than that in the control group at age 17 wk but not at ages 39 and 52 wk. By ages 17 and 39 wk, the red blood cell DHA concentration in the LCP-supplemented group was more than double and more than triple, respectively, that in the control group. Growth of infants fed LCP-supplemented and control formulas did not differ significantly, and both diets were well tolerated. CONCLUSION: LCP supplementation of term infant formula during the first year of life yields clear differences in visual function and in total red blood cell lipid composition.

Item Type: Article
Keywords: Arachidonic Acid, Docosahexaenoic Acids, Double-Blind Method, Evoked Potentials, Visual, Female, Food, Formulated, Humans, Infant Food, Infant, Newborn, Linear Models, Lipids, Male, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Visual Acuity, Arachidonic Acid, administration & dosage, therapeutic use, Docosahexaenoic Acids, administration & dosage, therapeutic use, Double-Blind Method, Evoked Potentials, Visual, drug effects, Female, Food, Formulated, Humans, Infant Food, Infant, Newborn, Linear Models, Lipids, blood, Male, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Visual Acuity, drug effects
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Population Health (2012- ) > Dept of Nutrition and Public Health Interventions Research (2003-2012)
Faculty of Epidemiology and Population Health > Dept of Population Health (2012- )
Research Centre: Centre for Global Non-Communicable Diseases (NCDs)
PubMed ID: 15817866
Web of Science ID: 228275400023
URI: http://researchonline.lshtm.ac.uk/id/eprint/12850

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
329Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item